XML 42 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Reserve for Losses and Loss Adjustment Expenses (Tables)
9 Months Ended
Sep. 30, 2021
Insurance [Abstract]  
Schedule of Reserve for Losses and Loss Adjustment Expenses
Activity in the reserve for losses and loss adjustment expenses is summarized as follows:
(In thousands)Nine Months Ended September 30, 2021Nine Months Ended September 30, 2020Year Ended December 31, 2020
Balance, beginning of year$2,417,179 $2,346,526 $2,346,526 
Less reinsurance recoverables on unpaid losses and loss adjustment expenses385,087 390,708 390,708 
Net balance, beginning of year2,032,092 1,955,818 1,955,818 
Net reserves acquired from NORCAL acquisition1,089,103 — — 
Net losses:
Current year(1)(2)(3)
582,235 555,969 711,846 
Favorable development of reserves established in prior years, net
(27,205)(34,557)(50,399)
Total555,030 521,412 661,447 
Paid related to:
Current year(62,276)(60,449)(83,204)
Prior years(457,578)(400,930)(501,969)
Total paid(519,854)(461,379)(585,173)
Net balance, end of period3,156,371 2,015,851 2,032,092 
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses476,315 391,637 385,087 
Balance, end of period$3,632,686 $2,407,488 $2,417,179 
(1) Current year net losses for the nine months ended September 30, 2021 included $4.3 million of amortization of the negative VOBA associated with NORCAL's assumed unearned premium, which is being amortized over a period in proportion to the earn-out of the associated premium as a reduction to current accident year net losses (see Note 2). Additionally, current year net losses for the nine months ended September 30, 2021 included $5.1 million related to a Custom Physician tail policy in the Specialty P&C segment.
(2) Current year net losses for the nine months ended September 30, 2021 included incurred losses of $2.9 million related to an assumed reinsurance arrangement entered into during the first quarter of 2021 in the Specialty P&C segment (see Note 5).
(3) Current year net losses for the nine months ended September 30, 2020 and the year ended December 31, 2020 included the impact of a large national healthcare account in the Specialty P&C segment including losses of $60.0 million associated with a tail policy and $9.2 million of amortization of a related PDR. For additional information, see Note 7 of the Notes to Consolidated Financial Statements included in ProAssurance's December 31, 2020 report on Form 10-K.